Progress of novel immunotherapy agents in non-Hodgkin lymphoma

VernacularTitle:非霍奇金淋巴瘤新型免疫治疗药物的研究进展
Author: Ya ZHANG ; Xin WANG
Keywords: Lymphoma,non-Hodgkin; Immunotherapy; Targeted therapy
From: Journal of Leukemia & Lymphoma 2016;25(12):764-768
CountryChina
Language:Chinese
Abstract: Novel targeted drugs and clinical trails have become the research highlights of non-Hodgkin lymphoma (NHL) recently. With further studies on immunotherapy in NHL, a number of novel immunotherapeutic targeted agents have been developed, some of which also had showed clinical benefit in early-stage study. The advances on novel immunotherapeutic targeted agents in NHL will be comprehensively reviewed in this paper from three aspects, including the targeted monoclonal antibody of cell surface antigen, the targeted therapy of cell signal transduction pathway and lymphoma microenvironment.